MithraGen Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

MithraGen General Information

Description

Developer of immunotherapies for T and B cells for the treatment and prevention of cancers and infectious diseases. The company develops immunotherapies incorporating Class I and II restricted epitopes for the treatment of cancers and infectious diseases that currently have no satisfactory therapy.

Contact Information

Formerly Known As
MithraTech
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 8030 El Rio
  • Houston, TX 77054
  • United States
+1 (713)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 8030 El Rio
  • Houston, TX 77054
  • United States
+1 (713)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MithraGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Jan-2008 Completed Generating Revenue
3. Early Stage VC (Series B) 12-Mar-2004 Completed Startup
2. Early Stage VC (Series A) $1.89M $1.89M Completed
1. Accelerator/Incubator Completed Startup
To view MithraGen’s complete valuation and funding history, request access »

MithraGen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view MithraGen’s complete cap table history, request access »

MithraGen Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BCM Ventures Venture Capital Minority
Emerging Technology Partners (Venture Capital) Venture Capital Minority
Wake Forest Baptist Corporation
To view MithraGen’s complete investors history, request access »

MithraGen FAQs

  • When was MithraGen founded?

    MithraGen was founded in 2000.

  • Where is MithraGen headquartered?

    MithraGen is headquartered in Houston, TX.

  • What industry is MithraGen in?

    MithraGen’s primary industry is Biotechnology.

  • Is MithraGen a private or public company?

    MithraGen is a Private company.

  • What is MithraGen’s current revenue?

    The current revenue for MithraGen is .

  • How much funding has MithraGen raised over time?

    MithraGen has raised $3.99M.

  • Who are MithraGen’s investors?

    BCM Ventures, Emerging Technology Partners (Venture Capital), and Wake Forest Baptist have invested in MithraGen.

  • When was MithraGen acquired?

    MithraGen was acquired on 01-Jan-2008.

  • Who acquired MithraGen?

    MithraGen was acquired by Northwest Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process